Plenary Session 2:Update on the genetics of Parkinson’s disease: cause, risk, and protection?

Plenary Session 2:Update on the genetics of Parkinson’s disease: cause, risk, and protection?

Hall 1
Plenary

Information

Convened by Parkinson's UK

Professor Christine Klein

Chair: Dr David Dexter

Theme
Ageing & neurodegeneration
Parkinson's UKStand 25We’re Parkinson’s UK. The charity that’s here to support every Parkinson’s journey, every step of the way. We don’t wait for change, we make it happen. Campaigning for better health and care. Funding research into groundbreaking new treatments. Running life-changing support services. We are currently funding over £13m towards 39 research grants. And through our drug discovery programme, the Parkinson’s Virtual Biotech, we've committed £30m towards new drug discovery and development projects for Parkinson’s. The charity uses insight from people with the condition to shape and prioritise its work, as well as improving the experiences of taking part in research. We will be sharing information about the ways we can support your research from funding opportunities to guidance and facilitation of patient and public involvement. Come and chat to us!

Speakers

CK
Christine Klein
ProfessorUniversity of Lübeck

Registered attendees

Abhishek Saha
Abhishek Saha
Medical StudentUniversity of Oxford
Akshaykumar Kamble
Akshaykumar Kamble
NeuroradiologistUniversity Hospital Coventry and Warwickshire
AP
Aleksandra Pokrovskaya
PhD StudentUniversity of Edinburgh, The Roslin Institute